News Novartis' LEE011 on fast track to challenge Ibrance US regulator grants fast review for breast cancer drug.
News Debiopharm teams up with Merck KGaA and Pfizer in lung cance... Swiss biotech looks to combine small molecule drug with immunotherapy.
News J&J says ready to fend off Remicade competitor Pfizer's rival launch should be considered "at risk", says J&J
News Pfizer set for US launch of Remicade biosimilar Pfizer gearing up for US launch late next month.
UK & Europe Pfizer's Lyrica patent appeal fails in UK Generics firms free to exploit gap in Pfizer's patent defences.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.